BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bateni Z, Rahimi HR, Hedayati M, Afsharian S, Goudarzi R, Sohrab G. The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial. Phytother Res 2021;35:3945-53. [PMID: 33851448 DOI: 10.1002/ptr.7109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Akter S, Akhter H, Chaudhury HS, Rahman MH, Gorski A, Hasan MN, Shin Y, Rahman MA, Nguyen MN, Choi TG, Kim S. Dietary carbohydrates: Pathogenesis and potential therapeutic targets to obesity‐associated metabolic syndrome. BioFactors. [DOI: 10.1002/biof.1886] [Reference Citation Analysis]
2 Nurcahyanti ADR, Cokro F, Wulanjati MP, Mahmoud MF, Wink M, Sobeh M. Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management. Front Nutr 2022;9:891339. [PMID: 35757255 DOI: 10.3389/fnut.2022.891339] [Reference Citation Analysis]
3 Surma S, Sahebkar A, Urbański J, Penson PE, Banach M. Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most? Front Nutr 2022;9:865497. [DOI: 10.3389/fnut.2022.865497] [Reference Citation Analysis]
4 Fu Y, Ho W, Kang N, Tsai M, Wu J, Huang L, Weng C. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Front Pharmacol 2022;13:863082. [DOI: 10.3389/fphar.2022.863082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bateni Z, Behrouz V, Rahimi HR, Hedayati M, Afsharian S, Sohrab G. Effects of nano-curcumin supplementation on oxidative stress, systemic inflammation, adiponectin, and NF-κB in patients with metabolic syndrome: A randomized, double-blind clinical trial. Journal of Herbal Medicine 2022;31:100531. [DOI: 10.1016/j.hermed.2021.100531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Liu J, Luo W, Chen Q, Chen X, Zhou G, Sun H. Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota. Cancer Chemother Pharmacol. [DOI: 10.1007/s00280-021-04385-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Urošević M, Nikolić L, Gajić I, Nikolić V, Dinić A, Miljković V. Curcumin: Biological Activities and Modern Pharmaceutical Forms. Antibiotics 2022;11:135. [DOI: 10.3390/antibiotics11020135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
8 Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Curcumin in Metabolic Health and Disease. Nutrients 2021;13:4440. [PMID: 34959992 DOI: 10.3390/nu13124440] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Quispe C, Cruz-Martins N, Manca ML, Manconi M, Sytar O, Hudz N, Shanaida M, Kumar M, Taheri Y, Martorell M, Sharifi-Rad J, Pintus G, Cho WC. Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases. Oxid Med Cell Longev 2021;2021:3149223. [PMID: 34584616 DOI: 10.1155/2021/3149223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ashtary-Larky D, Rezaei Kelishadi M, Bagheri R, Moosavian SP, Wong A, Davoodi SH, Khalili P, Dutheil F, Suzuki K, Asbaghi O. The Effects of Nano-Curcumin Supplementation on Risk Factors for Cardiovascular Disease: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials. Antioxidants (Basel) 2021;10:1015. [PMID: 34202657 DOI: 10.3390/antiox10071015] [Cited by in F6Publishing: 9] [Reference Citation Analysis]